Editor: Atta-ur-Rahman FRS

Frontiers in Clinical Drug Research-Hematology

Volume 2

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2352-3239 (Print)
ISBN: 978-1-68108-182-3 (Print)
ISBN: 978-1-68108-181-6 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810818161160201

Introduction

Frontiers in Clinical Drug Research – Hematology is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of hematological disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of anemias, coagulopathies, vascular diseases and hematological malignancies. Reviews in this series also include research on specific antibody targets, therapeutic methods, genetic hemoglobinopathies and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Hematology is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of hematology, oncology and vascular pharmacology.

The second volume of this series features 5 chapters that cover a variety of topics including:

  • - Chronic myeloid leukemia
  • - ispecific and multivalent antibodies
  • - Natural Killer cells therapy for bone marrow transplantation
  • - Nanoparticles in health and disease
  • - Monoclonal antibody therapy for lymphoma

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. iii
Atta-ur-Rahman
Download Free

Molecular and Therapeutic Clues in Chronic Myeloid Leukemia

- Pp. 3-80 (78)
Gabriella Marfe, Giovanna Mirone, Arvind Shukla, Carla Di Stefano
View Abstract

Bispecific and Multivalent Antibodies - New Swords to Combat Hematological Malignancies

- Pp. 81-131 (51)
Michael Stanglmaier, Juergen Hess
View Abstract

Natural Killer Cells as an Immune Cell Therapy Option for Bone Marrow Transplantation in Hematological Malignancies: Implications for New Therapies Based on Lipid Transfer and Cell-to- Cell Communication

- Pp. 132-175 (44)
Beatriz Martín-Antonio, Nuria Martínez-Cibrian, Alvaro Urbano- Ispizua, Ciril Rozman
View Abstract

Nanoparticles in Health and Disease: An Overview of Nanomaterial Hazard, Benefit and Impact on Public Health Policy - Current State and Outlook

- Pp. 176-255 (80)
Stanislav Janousek, Dagmar Jirova, Kristina Kejlova, Marketa Dvorakova
View Abstract

Monoclonal Antibodies in Lymphoma

- Pp. 256-299 (44)
Esmeralda Chi-yuan Teo, Colin Phipps
View Abstract

Subject Index

- Pp. 300-305 (6)
Atta-ur-Rahman
Download Free

RELATED BOOKS